10.6084/m9.figshare.4570033.v1 Silver S.A. Silver S.A. Harel Z. Harel Z. Harvey A. Harvey A. Adhikari N.K. Adhikari N.K. Slack A. Slack A. Acedillo R. Acedillo R. Jain A.K. Jain A.K. Richardson R.M. Richardson R.M. Chan C.T. Chan C.T. Chertow G.M. Chertow G.M. Bell C.M. Bell C.M. Wald R. Wald R. Supplementary Material for: Improving Care after Acute Kidney Injury: A Prospective Time Series Study Karger Publishers 2017 Acute kidney injury Chronic kidney disease Continuity of care Quality improvement Transitions in care 2017-01-20 12:50:40 Figure https://karger.figshare.com/articles/figure/Supplementary_Material_for_Improving_Care_after_Acute_Kidney_Injury_A_Prospective_Time_Series_Study/4570033 <strong><em>Background:</em></strong> Acute kidney injury (AKI) complicates 15-20% of hospitalizations, and AKI survivors are at increased risk of chronic kidney disease and death. However, less than 20% of patients see a nephrologist within 3 months of discharge, even though a nephrologist visit within 90 days of discharge is associated with enhanced survival. To address this, we established an AKI Follow-Up Clinic and characterized the patterns of care delivered. <b><i>Methods:</i></b> We conducted a prospective time series study. All hospitalized patients who developed Kidney Disease Improving Global Outcomes (KDIGO) stage 2 or 3 AKI were eligible. The pre-intervention period consisted of electronic reminders to the nephrology consults and cardiovascular surgery services to refer to the AKI Follow-Up Clinic. In the post-intervention period, eligible patients were automatically scheduled into the AKI Follow-Up Clinic at discharge. The primary outcome was the percentage of KDIGO stages 2-3 AKI survivors assessed by a nephrologist within 30 days of discharge. <b><i>Results:</i></b> In the pre-intervention period, 8 of 46 patients (17%) were seen by a nephrologist within 30 days after discharge, and no additional patients were seen for 90 days. In the post-intervention period, 17 of 69 patients (25%) were seen by a nephrologist within 30 days after discharge (p = 0.36), with an additional 30 patients seen in 90 days (47 of 69, 68%, p < 0.001). The mean serum creatinine was 99 (SD 35) µmol/l prior to hospitalization and 133 (58) µmol/l at 3 months. Fifty-five of 79 patients (70%) received at least 1 medical intervention at their first AKI Follow-Up Clinic visit. <b><i>Conclusions:</i></b> An AKI Follow-Up Clinic with an automatic referral process increased the proportion of patients seen at 90 days, but not 30 days post discharge. Being seen in the AKI Follow-Up Clinic was associated with interventions in most patients. Future research is needed to evaluate the effect of the AKI Follow-Up Clinic on patient-centered outcomes, but physicians should be aware that AKI survivors may benefit from close outpatient follow-up and a multipronged approach to care similarly for other high-risk populations.